AltTox Editorial Board and Management Team members at SOT 2015

Home / Community Blog / AltTox Editorial Board and Management Team members at SOT 2015

Community Blog

AltTox Editorial Board and Management Team members at SOT 2015

Author: Marilyn Matevia, The Humane Society of the United States (HSUS)

(This is an updated version of the feature that appeared in the recent AltTox Digest.)

AltTox Management Team and Editorial Board members will be at the Society of Toxicology’s 2015 meeting in San Diego. Here is a partial list of posters, presentations, and workshops they will offer.

  • Editorial Board member Ian Kimber will deliver the SOT Distinguished Scholar Award Lecture on Wednesday, March 25, at 12:30 PM. Dr. Kimber will receive the Distinguished Scholar Award at the Honors and Awards Ceremony, Sunday, March 22 at 5:15 PM local time.
  • Management Team and Editorial Board member George Daston will debate Maurice Whelan (JRC, EURL ECVAM) in the SOT/EUROTOX debate, “In Vitro Alternatives Are Ready to Be Implemented,” Monday March 23, 4:45-6:00 PM. Dr. Daston will also present two talks:
    • “Predicting Systemic Toxicity Using Cheminformatics and High- Throughput Toxicogenomics,” in the Scientific Workshop, “Application of High-Throughput In Vitro Assays in Assessing Small Molecule Safety session,” Wednesday, March 25, 9:00 AM to 11:45 AM.
    • “Comparison of a Full-Genome Microarray with the L1000 Platform” in the workshop, “Integrating Gene Expression Profiling into High-throughput Toxicity Testing,” Wednesday, March 25, 1:30 PM to 4:15 PM.
  • AltTox co-founder Martin L. Stephens will co-chair a session, “An Ounce of Prevention Is Worth a Pound of Cure: How 21st Century Toxicology Can Transform Product Safety Assessments and Design of Lower-Toxicity Products,” on Tuesday, March 24, 1:30 PM to 4:15 PM.
  • Editorial Board member Emanuela Corsini is co-author of a poster, “Optimization of the THP-1 Activation Assay to Detect Pharmaceuticals with Potential to Cause Immune-Mediated Drug Reactions,” in the “Inflammation: Methods and Mechanisms” session, March 23, 9:30 AM to 12:30 PM (Abstract 159, Poster Board 223).
  • Management Team member Kristie Sullivan and Editorial Board member Grace Patlewicz are co-authors on a poster, “Constructing an Adverse Outcome Pathway for Sensitization of the Respiratory Tract: Network Thinking Meets Regulatory Utility” in the Autoimmunity/Hypersensitivity session, March 23, 1:00-4:30 PM (Abstract 666, Poster Board 518).
  • Management Team members Catherine Willett and Kristie Sullivan are coordinating an ancillary workshop, “AOPs 201”: A Seminar on Development, Recording, and Use of Adverse Outcome Pathways, on Monday, March 23, 5:00 PM–7:30 PM at the San Diego Marriott Marquis & Marina (Headquarters), Marina Ballroom F.
  • Catherine Willett will also give an update on Human Toxicology Project Consortium (HTPC) activities at a satellite meeting co-sponsored by the HTPC and CAAT, “Updates on Activities Related to 21st Century Toxicology and Evidence-based Toxicology: Invited Presentations and Open Microphone,” March 26, 12:30-4:00 PM, in the Hillcrest Room of the Manchester Grand Hyatt San Diego.
  • Editorial Board member Joao Barroso is co-author of a poster, “Effectiveness of Toxicology-Based Webinars in Promoting Nonstandard Methods Using REACH As a Case Study” (Abstract 1915, Poster Board 5150).
  • Editorial Board member Joshua Harrill is co-author of a poster, “Repeated TCDD Exposure Produces Region-Specific Cellular Effects in Laser Capture Microdissected Centrilobular and Periportal Hepatocytes from the Rat Liver” (Abstract 1004, Poster Board 259).
  • Editorial Board member Albert Li is presenting a talk in an exhibitor-hosted session on March 24th, 10:00 – 11:00 AM (Room 24C), “In vitro hepatotoxicity evaluation with cryopreserved human, animal and transgenic animal hepatocytes.” Dr. Li is also co-author on two posters:
    • “Elucidation of the Roles of P450 CYP3A and Uptake Transporters in Species Differences in Drug Toxicity Using Cryopreserved Knockout and Humanized Transgenic Mouse Hepatocytes” (Abstract 89, Poster Board 122), and
    • “Plateable Cryopreserved Human Hepatocytes Pooled from Multiple Donors for In Vitro Evaluation of Adverse Drug Properties (Abstract 695, Poster Board 549).